Amlogenyx
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
77 Digital Dr Ste 200, Novato, Californi...Website
www.amlogenyx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Amlogenyx
Amlogenyx is focused on developing a novel gene therapy aimed at reducing amyloid accumulation in the brain to prevent and treat Alzheimer's disease and other neurodegenerative disorders. The company leverages insights from lysosomal dysfunction and protease deficiencies to create innovative treatments that target the underlying causes of these diseases. Their research demonstrates that increasing levels of the protease PPCA in the brain can effectively reduce amyloid plaque accumulation, offering a potential single-shot treatment for Alzheimer's. Amlogenyx's intended clients include patients suffering from Alzheimer's disease and related neurodegenerative conditions.Explore more
Popular SearchesAmlogenyxSIC Code 28,283NAICS Code 32,325Show moreAmlogenyx Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amlogenyx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Amlogenyx has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Amlogenyx recently announced quarterly report
Click to see if Amlogenyx had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Amlogenyx has new funding data
Product Launch: Get notified when Amlogenyx launches new products
Congratulate Masked Content for being promoted to Masked Content at Amlogenyx
Check out if Amlogenyx is spiking on competitors!
Amlogenyx, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Amlogenyx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Amlogenyx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amlogenyx.
Amlogenyx News & Media
Amlogenyx Presents Preclinical Data on AM805, a Potentially Transformative Investigational Gene Therapy for Alzheimer’s Disease
A novel approach using a lysosomal enzyme to prevent and reverse amyloid accumulation inside as well as outside neurons, with greater potency, delivered in a one-time gene therapyAmlogenyx Announces Positive Preclinical Data on AM805, a Potent Amyloid-Degrading Protease for the Treatment of Alzheimer’s Disease
Novel and potent catalytic approach that directly clears amyloid on the inside of neurons as well as reduces amyloid plaques with the potential to be superior to monoclonal antibodies and restore neuronal function while halting or reversing disease progression
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Amlogenyx
Sign Up For FreeTo access detailed company insights
Amlogenyx is focused on developing a novel gene therapy aimed at reducing amyloid accumulation in the brain to prevent and treat Alzheimer's disease and other neurodegenerative disorders. The company leverages insights from lysosomal dysfunction and protease deficiencies to create innovative treatments that target the underlying causes of these dis... Read More
